Search

The ViRNAExTM - Viral Extraction solution is designed for rapid (15 min) isolation of viral RNA and DNA (nucleic acids - NA) from nasopharyngeal swabs, buccal swabs, sputum and saliva using specially developed technology to remove inhibitors.

The isolation is designed for use on low nucleic acid samples. Isolated NA are suitable for amplification techniques such as RT-PCR of viral NA in clinical samples. 

Package contents: 10 mL (100 isolations).

The ViRNAExTM - Viral Extraction solution is designed for rapid (15 min) isolation of viral RNA and DNA (nucleic acids - NA) from nasopharyngeal swabs, buccal swabs, sputum and saliva using specially developed technology to remove inhibitors.

The isolation is designed for use on low nucleic acid samples. Isolated NA are suitable for amplification techniques such as RT-PCR of viral NA in clinical samples.

Package contents: 50 mL (500 isolations).

Rapid immunochromatographic test for the qualitative detection of Chlamydia antigen in female cervical swab, male urethral swab and male urine specimens to aid in the diagnosis of Chlamydia infection.

Female Cervical Swab Specimens 

Relative Sensitivity: 93.3% (81.7%-98.6%)*

Relative Specificity: 97.5% (93.7%-99.3%)*

Relative accuracy: 96.6% (93.1%-98.6%)*  
* 95% Confidence Intervals

Male Urethral Swab Specimens

Relative Sensitivity: 86.2% (74.6%-93.9%)*

Relative Specificity: 95.8% (90.5%-98.6%)*

Relative accuracy: 92.7% (87.8%-96.1%)*

* 95% Confidence Intervals 

Male Urine Specimens

Relative Sensitivity: 94.6% (81.8%-99.3%)*

Relative Sensitivity: >99.9% (95.1%-100%)*

Relative Accuracy: 97.9% (92.7%-99.7%)* 

* 95% Confidence Intervals

Rapid immunochromatographic test for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigen in human nasopharyngeal swab samples as an aid in rapid diagnosis of Coronavirus (Covid-19) infection.

Test sensitivity: 97.3% (95% CI: 90.0% - 99.8%)

Test specificity: 100.0% (95% CI: 96.6% - 100%) 

Relative accuracy: 98.8% (95% CI: 91.8% - 99.9%)

* Confidence Intervals

Rapid immunochromatographic test for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigen in human nasopharyngeal swab samples as an aid in rapid diagnosis of Coronavirus (Covid-19) infection.

Test sensitivity: 97.3% (95% CI: 90.0% - 99.8%)

Test specificity: 100.0% (95% CI: 96.6% - 100%) 

Relative accuracy: 98.8% (95% CI: 91.8% - 99.9%)

* Confidence Intervals

Rapid immunochromatographic test for the qualitative detection of Infectious Mononucleosis (IM) heterophile antibodies in whole blood, serum or plasma as an aid in the diagnosis of Infectious Mononucleosis. IM is caused by the Epstein-Barr virus, which is a member of the herpesvirus family.

Relative Sensitivity: 97.6% (95% CI*: 93.1%-99.5%)*

Relative Specificity: 97.8% (95% CI*: 94.4%-99.4%)*          

Overall Accuracy: 97.7% (95% CI*: 95.3%-99.1%)*

 * Confidence Intervals  

Rapid immunochromatographic test for the qualitative detection of IgM antibody to Hepatitis A Virus (HAV) in serum or plasma.

Relative Sensitivity: 95.2% (95% CI*: 89.8%-98.2%)

Relative Specificity: 99.1% (95% CI*: 97.8%-99.8%)

Overall Accuracy: 98.3% (95% CI*: 96.9%-99.2%)

*Confidence Intervals

Rapid immunochromatographic test for the qualitative detection of anti-TB antibodies (Isotypes IgG, IgM and IgA) in whole blood, serum or plasma specimens. 

Relative Sensitivity: 86.4% (95% CI*: 78.5%-92.2%)

Relative Specificity: 99.0% (95% CI*: 97.7%-99.7%)

Relative Accuracy: 96.7% (95% CI*: 95.0%-98.0%)

* Confidence Intervals 

Rapid immunochromatographic test for the semiquantitative detection of human Prostate-specific antigen (PSA) in serum/plasma. The test is intended as an aid in monitoring patients for prostate disease progression or the response to therapy or for the detection of recurrent or residual disease.

Relative Sensitivity: 99.0% (95% CI:*96.6%-99.9%) 

Relative Specificity: 99.2% (95% CI:*97.5%-99.8%) 

Overall accuracy: 99.1% (95% CI:*97.9%-99.7%)  

* Confidence Intervals